Novo Nordisk Logo
Design Image 1
Design Image 2
Design Image 3 Home Hemophilia and Joint Health Surgery Insurance Resources Design Image 4 Design Image 5
Design Image 6
Design Image 7
Design Image 8
Search Icon
Design Image 9 Design Image 10 Design Image 11
Design Image 12
Designer Image 40 Overview
Hemophilia
Inhibitors
Joint Health
Managing Joint Pain
Joint Damage
Designer Image 41
What are Inhibitors
Risk of Developing an Inhibitor
Tests for Types of Inhibitors
Treatment for Hemophilia With a Inhibitors
Design Image 14
Design Image 15
Design Image 16
RISK OF DEVELOPING AN INHIBITOR
About 1 in 3 people with severe hemophilia A may develop inhibitors at some time in their lives.18, 19 In people with severe hemophilia B, inhibitors develop in only about 1 in 25 people.20 The risk of getting inhibitors is higher in: children, people who have severe hemophilia, people with a family history of inhibitors, and people of African descent.19, 21

 On average, most inhibitors will occur after 5 to 50 treatments with factor replacement therapy and before the age of 5 years. Inhibitors cannot be prevented and can occur at any time.22
 
 
Design Image 17
Design Image 18
Select Video Is Surgery Right for Me
Design Image 19
Design Image 20
Site MapLegalPrivacy PolicyDisclamer Design Image 21
Design Image 22
Design Image 23
Design Image 24
©2007 Novo Nordisk Inc. Design Image 26
Design Image 27